Empowering Women in Biotech

Anne Dickinson is Emeritia Professor of Translational and Clinical Medicine at Newcastle University, where she used human skin based in vitro assays for predicting graft versus host disease (GvHD). Her research work has been extensively published in over 100 peer-reviewed journals.

Anne was also a Health Professional Clinical Scientist and was the Director of Newcastle Cellular Therapy Facility until her retirement and has experience in the regulatory framework involved in Good Manufacturing Practice (GMP) for the development of Advanced Therapy Medicinal Products (ATMPs).

Anne’s research led to the founding of Alcyomics in 2007, where the skin based assays were modified for predicting adverse immune skin and systemic responses to compounds including chemicals, cosmetics, pharmaceuticals and cellular therapies. Patents have been granted on the assays within Europe and the USA.

Anne has over 15 years’ experience in developing commercial contracts for some of the top twenty pharma companies as clients and a wealth of experience in obtaining successful commercial and research funding at the national and international level. She has co-ordinated international EU projects for 20 years.